User profiles for Karen Doucette

Karen Doucette

University of Alberta
Verified email at ualberta.ca
Cited by 3895

Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature

LC Ivers, D Kendrick, K Doucette - Clinical Infectious Diseases, 2005 - academic.oup.com
Background . Despite the advent of effective combination antiretroviral drug therapy (ART)
for the treatment of human immunodeficiency virus (HIV) infection, many doubt the feasibility …

Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients

K Doucette, JA Fishman - Clinical infectious diseases, 2004 - academic.oup.com
Nontuberculous mycobacteria (NTM) are ubiquitous environmental organisms. In immunocompetent
hosts, they are a rare cause of disease. In immunocompromised hosts, disease due …

Occult hepatitis B virus infection in a North American community-based population

…, S Caouette, LE Nicolle, A Gutkin, K Doucette… - Journal of …, 2005 - Elsevier
BACKGROUND/AIMS: Occult hepatitis B virus (HBV) infection [HBV-DNA detection in hepatitis
B surface antigen (HBsAg)-negative individuals] may cause acute and/or chronic liver …

Management of chronic hepatitis C: consensus guidelines

M Sherman, S Shafran, K Burak, K Doucette… - Canadian Journal of …, 2007 - hindawi.com
Since the last consensus conference on the management of chronic viral hepatitis, a number
of studies looking at modifications of the standard course of treatment have been published…

A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients

…, S Studer, D Pakstis, K McCurry, K Doucette… - …, 2010 - journals.lww.com
Background. Community-acquired respiratory viral infections (RVIs) are common in lung
transplant patients and may be associated with acute rejection and bronchiolitis obliterans …

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant: a phase 3, randomized …

…, D Kumar, YJ Chiang, K Doucette… - Clinical Infectious …, 2020 - academic.oup.com
Background The incidence of herpes zoster is up to 9 times higher in immunosuppressed
solid organ transplant recipients than in the general population. We investigated the …

Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: analysis of 5552 patients from 12 cohorts

…, RS Brown Jr, P Lampertico, K Doucette… - Liver …, 2020 - Wiley Online Library
Background and aims Achieving sustained virological response (SVR; cure) in hepatitis C
patients using a simple regimen is key to making elimination by 2030 possible. In the largest …

Pneumocystis jirovecii: a review with a focus on prevention and treatment

RB Weyant, D Kabbani, K Doucette, C Lau… - Expert opinion on …, 2021 - Taylor & Francis
Introduction: Pneumocystis jirovecii (PJ) is an opportunistic fungal pathogen that can cause
severe pneumonia in immunocompromised hosts. Risk factors for Pneumocystis jirovecii …

Management of hepatitis B virus infection: 2018 guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and …

…, F Alvarez, CL Cooper, KE Doucette… - Canadian Liver …, 2018 - canlivj.utpjournals.press
Hepatitis B virus (HBV) infection is an important public health problem in Canada. In keeping
with evolving evidence and understanding of HBV pathogenesis, the Canadian Association …

Viral hepatitis: guidelines by the American society of transplantation infectious disease community of practice

H Te, K Doucette - Clinical Transplantation, 2019 - Wiley Online Library
These updated guidelines from the Infectious Diseases Community of Practice of the American
Society of Transplantation review the diagnosis, prevention, and management of viral …